The Genomic Answers for Children’s Health Act of 2026 mandates Medicaid coverage for whole genome and whole exome sequencing for children with specific medical needs, creating a new, guaranteed revenue stream for genomic sequencing and bioinformatics companies. This expands the addressable market for these services within the Medicaid program. This bill is a direct financial boon for companies providing sequencing technology and data analysis.
Impact: 5/10(Early stage (action not classified))HR7118Congressional Bill